Skip to main content
. 2020 Aug 14;12(8):769. doi: 10.3390/pharmaceutics12080769

Figure 2.

Figure 2

FE-SEM (left) and TEM (right) images of PCT@LIP (A) as control and PCT@LIP/NOR (B) containing 0.2% NOR (w/v) formulations. The used magnifications are displayed in the images.